BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36075530)

  • 1. Multimodality Therapy in Patients With Primary Pericardial Mesothelioma.
    Offin M; De Silva DL; Sauter JL; Egger JV; Yorke E; Adusumilli PS; Rimner A; Rusch VW; Zauderer MG
    J Thorac Oncol; 2022 Dec; 17(12):1428-1432. PubMed ID: 36075530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.
    Kapeles M; Gensheimer MF; Mart DA; Sottero TL; Kusano AS; Truong A; Farjah F; Laramore GE; Stelzer KJ; Patel SA
    Am J Clin Oncol; 2018 Jan; 41(1):30-35. PubMed ID: 26353120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
    Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
    Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
    Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
    Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
    Vigneswaran WT; Kircheva DY; Ananthanarayanan V; Watson S; Arif Q; Celauro AD; Kindler HL; Husain AN
    Ann Thorac Surg; 2017 Mar; 103(3):962-966. PubMed ID: 27765170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.
    Galateau Salle F; Le Stang N; Nicholson AG; Pissaloux D; Churg A; Klebe S; Roggli VL; Tazelaar HD; Vignaud JM; Attanoos R; Beasley MB; Begueret H; Capron F; Chirieac L; Copin MC; Dacic S; Danel C; Foulet-Roge A; Gibbs A; Giusiano-Courcambeck S; Hiroshima K; Hofman V; Husain AN; Kerr K; Marchevsky A; Nabeshima K; Picquenot JM; Rouquette I; Sagan C; Sauter JL; Thivolet F; Travis WD; Tsao MS; Weynand B; Damiola F; Scherpereel A; Pairon JC; Lantuejoul S; Rusch V; Girard N
    J Thorac Oncol; 2018 Aug; 13(8):1189-1203. PubMed ID: 29723687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant pleural mesothelioma: Comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions.
    Larose F; Quigley N; Lacasse Y; Martel S; Lang-Lazdunski L
    Lung Cancer; 2021 Jun; 156():151-156. PubMed ID: 33962765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of failure following surgical resection for malignant pleural mesothelioma.
    Jänne PA; Baldini EH
    Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Pericardial Mesothelioma: A Population-Based Propensity Score-Matched Analysis.
    Brydges H; Yin K; Balasubramaniyan R; Lawrence KW; Luo R; Karlson KJ; McAneny DB; Edwards NM; Reardon MJ; Dobrilovic N
    Semin Thorac Cardiovasc Surg; 2022; 34(3):1113-1119. PubMed ID: 34320396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and relapse pattern after trimodality therapy for malignant pleural mesothelioma.
    Okubo K; Sonobe M; Fujinaga T; Shoji T; Sakai H; Miyahara R; Bando T; Date H; Shibuya K; Hiraoka M
    Gen Thorac Cardiovasc Surg; 2009 Nov; 57(11):585-90. PubMed ID: 19908112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
    Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
    Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.
    Opitz I; Bille A; Dafni U; Nackaerts K; Ampollini L; de Perrot M; Brcic L; Nadal E; Syrigos K; Gray SG; Aerts J; Curioni-Fontecedro A; Rüschoff JH; Monkhorst K; Weynand B; Silini EM; Bavaghar-Zaeimi F; Jakopovic M; Llatjos R; Tsimpoukis S; Finn SP; von der Thüsen J; Marti N; Dimopoulou G; Kammler R; Peters S; Stahel RA; Falcoz PE; Brunelli A; Baas P;
    J Thorac Oncol; 2023 Sep; 18(9):1233-1247. PubMed ID: 37356802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in Turkey.
    Kucukoner M; Ali Kaplan M; Inal A; Urakci Z; Abakay O; Cetin Tanrikulu A; Abakay A; Selim Sen H; Turkcu G; Senyigit A; Buyukbayram H; Isikdogan A
    J BUON; 2014; 19(1):164-70. PubMed ID: 24659659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimodality treatment of malignant pleural mesothelioma.
    Batirel HF; Metintas M; Caglar HB; Yildizeli B; Lacin T; Bostanci K; Akgul AG; Evman S; Yuksel M
    J Thorac Oncol; 2008 May; 3(5):499-504. PubMed ID: 18449002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pleural mesothelioma in Singapore.
    Yip CS; Koong HN; Loo CM; Fong KW
    Asian Pac J Cancer Prev; 2011; 12(5):1155-9. PubMed ID: 21875258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
    Nelson DB; Rice DC; Niu J; Atay S; Vaporciyan AA; Antonoff M; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao A; Gomez D; Giordano SH; Mehran R; Sepesi B
    J Clin Oncol; 2017 Oct; 35(29):3354-3362. PubMed ID: 28817374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.
    Saddoughi SA; Abdelsattar ZM; Blackmon SH
    Ann Thorac Surg; 2018 Feb; 105(2):432-437. PubMed ID: 29223422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.